Mechanical Circulatory Support as a Bridge to Pediatric Heart Transplantation: A 36-Year Single-Center Experience
The Thoracic and Cardiovascular Surgeon · 01.01.2026 · 74 (S 01 S 01) · S1-S70
DOI: 10.1055/s-0046-1817306 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Thoracic and Cardiovascular Surgeon, erschienen am 01.01.2026. Verfasst von M. Salem und 7 weiteren Autor:innen.
Abstract (Originalsprache)
All articles of this category (opens in new window)
Background
Despite advances in mechanical circulatory support (MCS) for pediatric patients, its use remains complex and is associated with significant perioperative and postoperative challenges, particularly in critically ill individuals. We conducted a retrospective analysis to compare outcomes between patients who received MCS prior to heart transplantation (HTx) and those who did not.
Methods
We reviewed records of all pediatric patients who underwent HTx at our center between 1988 and 2024. Comparative analyses were performed between patients with pre-HTx MCS and MCS-naïve patients, including baseline characteristics, perioperative outcomes, and long-term survival.
Results
Of 278 pediatric heart transplants performed, 38 (14%) recipients had pre-HTx MCS. MCS patients were significantly older, with 87% being older than 1 year at the time of transplant. Cardiomyopathy was more common among MCS patients compared with congenital heart disease (76% vs. 24%, p < 0.001). Waitlist times did not differ significantly between groups. During transplantation, median cardiopulmonary bypass time was longer in the MCS group (300 vs. 252 minutes, p = 0.05). Postoperatively, 30-day mortality was comparable between groups. However, postoperative hemodialysis was significantly more frequent in MCS patients (29% vs. 13.4%, p = 0.040). Long-term survival was similar, with 20-year Kaplan–Meier estimates of 70.0% for MCS patients and 70.2% for MCS-naïve patients ( p = 0.67).
Conclusion
Pretransplant MCS is associated with longer operative times and a higher incidence of postoperative hemodialysis, but does not adversely affect early or long-term survival following heart transplantation. These findings support the safe and effective use of MCS as a bridge to transplantation in pediatric patients. Publication History Article published online: 17 February 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
Zitieren
APA
Salem, M., Skrzypek, S., Thul, J., Al-Tawil, M., Haneya, A., Müller, M., Jux, C., & Akintürk, H. (2026). Mechanical Circulatory Support as a Bridge to Pediatric Heart Transplantation: A 36-Year Single-Center Experience. The Thoracic and Cardiovascular Surgeon, 74(S 01 S 01), S1-S70. https://doi.org/10.1055/s-0046-1817306
Vancouver
Salem M, Skrzypek S, Thul J, Al-Tawil M, Haneya A, Müller M, et al. Mechanical Circulatory Support as a Bridge to Pediatric Heart Transplantation: A 36-Year Single-Center Experience. The Thoracic and Cardiovascular Surgeon. 2026;74(S 01 S 01):S1-S70. doi:10.1055/s-0046-1817306
BibTeX
@article{Salem2026,
author = {Salem, M. and Skrzypek, S. and Thul, J. and Al-Tawil, M. and Haneya, A. and Müller, M. and Jux, C. and Akintürk, H.},
title = {Mechanical Circulatory Support as a Bridge to Pediatric Heart Transplantation: A 36-Year Single-Center Experience},
journal = {The Thoracic and Cardiovascular Surgeon},
year = {2026},
volume = {74},
number = {S 01 S 01},
pages = {S1--S70},
doi = {10.1055/s-0046-1817306}
}
EUVIMED